Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(6):446-454; doi:10.1093/jnci/94.6.446
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Correction (v94,p866)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sviderskaya, E. V.
Right arrow Articles by Bennett, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sviderskaya, E. V.
Right arrow Articles by Bennett, D. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 6, 446-454, March 20, 2002
© 2002 Oxford University Press


ARTICLE

p16Ink4a in Melanocyte Senescence and Differentiation

Elena V. Sviderskaya, Simon P. Hill, Tracy J. Evans-Whipp, Lynda Chin, Seth J. Orlow, David J. Easty, Sok Ching Cheong, David Beach, Ronald A. DePinho, Dorothy C. Bennett

Affiliations of authors: Department of Anatomy and Developmental Biology, St. George's Hospital Medical School, London, U.K.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; New York University Medical Center, New York, NY; Wolfson Institute for Biomedical Research, University College, London.

Correspondence to: Dorothy C. Bennett, Ph.D., St. George's Hospital Medical School, Department of Anatomy and Developmental Biology, Cranmer Terrace, London SW17 ORE, U.K. (e-mail: dbennett{at}sghms.ac.uk).

Background: The Ink4a-Arf tumor suppressor locus encodes two growth inhibitors, p16 and Arf, both of which are also implicated as effectors in cellular senescence. Because human germline defects in the INK4A-ARF locus are associated with familial melanoma, melanocytes may have unusual INK4A-ARF functions or controls of cell senescence. Because senescence is believed to be an anticancer mechanism, we investigated the role of Ink4a-Arf and its individual components in melanocyte senescence. Methods: Melanocytes were cultured from littermate mice with zero, one, or two functional copies of the Ink4a-Arf locus. Senescence was evaluated by cumulative population doubling curves and by the assessment of acidic {beta}-galactosidase (an indicator of senescence) expression. Pigmentation and cell size were evaluated by spectrophotometry and microscopy. p16 and Arf expression in primary and spontaneously immortalized melanocyte or melanocyte precursor cell lines were evaluated by immunoblotting. Retroviral vectors containing normal p16 and Arf complementary DNAs were used to restore expression of these genes in Ink4a-Arf–/– melanocytes. Results: Wild-type melanocytes (i.e., Ink4a-Arf+/+) senesced within 4–5 weeks of culture. Ink4a-Arf–/– melanocytes did not senesce and readily became immortal. Ink4a-Arf+/– melanocytes showed defective senescence. Senescent Ink4a-Arf+/+ melanocytes were heavily pigmented, but Ink4a-Arf+/– and Ink4a-Arf–/– melanocytes were less pigmented. All of six spontaneously immortalized melanocyte or melanocyte precursor lines from Ink4a-Arf+/+ mice lacked p16 protein expression, although most retained Arf protein expression. After restoration of p16 but not Arf expression, Ink4a-Arf–/– melanocytes stopped growing, became highly melanized, and expressed acidic {beta}-galactosidase. By contrast, restoration of Arf but not p16 expression led to cell death without evidence of senescence. Conclusion: Normal mouse melanocyte senescence and associated pigmentation require both copies of Ink4a-Arf and appear to depend more on p16 than on Arf function. Mutations of the INK4A-ARF locus may favor tumorigenesis from melanocytes by impairing senescence, cell differentiation, and (where ARF is disrupted) cell death.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Damek-Poprawa, T. Diemer, V. S. Lopes, C. Lillo, D. C. Harper, M. S. Marks, Y. Wu, J. R. Sparrow, R. A. Rachel, D. S. Williams, et al.
Melanoregulin (MREG) Modulates Lysosome Function in Pigment Epithelial Cells
J. Biol. Chem., April 17, 2009; 284(16): 10877 - 10889.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Sitaram, R. Piccirillo, I. Palmisano, D. C. Harper, E. C. Dell'Angelica, M. V. Schiaffino, and M. S. Marks
Localization to Mature Melanosomes by Virtue of Cytoplasmic Dileucine Motifs Is Required for Human OCA2 Function
Mol. Biol. Cell, March 1, 2009; 20(5): 1464 - 1477.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Cheung, A. Sharma, S. V. Madhunapantula, and G. P. Robertson
Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
Cancer Res., May 1, 2008; 68(9): 3429 - 3439.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Diwakar, D. Zhang, S. Jiang, and T. J. Hornyak
Neurofibromin as a regulator of melanocyte development and differentiation
J. Cell Sci., January 15, 2008; 121(2): 167 - 177.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
V. Delmas, F. Beermann, S. Martinozzi, S. Carreira, J. Ackermann, M. Kumasaka, L. Denat, J. Goodall, F. Luciani, A. Viros, et al.
beta-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development
Genes & Dev., November 15, 2007; 21(22): 2923 - 2935.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. Bataille, B. S. Kato, M. Falchi, J. Gardner, M. Kimura, M. Lens, U. Perks, A. M. Valdes, D. C. Bennett, A. Aviv, et al.
Nevus Size and Number Are Associated with Telomere Length and Represent Potential Markers of a Decreased Senescence In vivo
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1499 - 1502.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Ha, T. Ichikawa, M. Anver, R. Dickins, S. Lowe, N. E. Sharpless, P. Krimpenfort, R. A. DePinho, D. C. Bennett, E. V. Sviderskaya, et al.
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
PNAS, June 26, 2007; 104(26): 10968 - 10973.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. R. G. Setty, D. Tenza, S. T. Truschel, E. Chou, E. V. Sviderskaya, A. C. Theos, M. L. Lamoreux, S. M. Di Pietro, M. Starcevic, D. C. Bennett, et al.
BLOC-1 Is Required for Cargo-specific Sorting from Vacuolar Early Endosomes toward Lysosome-related Organelles
Mol. Biol. Cell, March 1, 2007; 18(3): 768 - 780.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. N. Hume, A. K. Tarafder, J. S. Ramalho, E. V. Sviderskaya, and M. C. Seabra
A Coiled-Coil Domain of Melanophilin Is Essential for Myosin Va Recruitment and Melanosome Transport in Melanocytes
Mol. Biol. Cell, November 1, 2006; 17(11): 4720 - 4735.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. Wasmeier, M. Romao, L. Plowright, D. C. Bennett, G. Raposo, and M. C. Seabra
Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes
J. Cell Biol., October 23, 2006; 175(2): 271 - 281.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. C. Theos, J. F. Berson, S. C. Theos, K. E. Herman, D. C. Harper, D. Tenza, E. V. Sviderskaya, M. L. Lamoreux, D. C. Bennett, G. Raposo, et al.
Dual Loss of ER Export and Endocytic Signals with Altered Melanosome Morphology in the silver Mutation of Pmel17
Mol. Biol. Cell, August 1, 2006; 17(8): 3598 - 3612.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Antonellis, W. R. Bennett, T. R. Menheniott, A. B. Prasad, S.-Q. Lee-Lin, NISC Comparative Sequencing Program, E. D. Green, D. Paisley, R. N. Kelsh, W. J. Pavan, et al.
Deletion of long-range sequences at Sox10 compromises developmental expression in a mouse model of Waardenburg-Shah (WS4) syndrome
Hum. Mol. Genet., January 15, 2006; 15(2): 259 - 271.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. L. Chabrillat, C. Wilhelm, C. Wasmeier, E. V. Sviderskaya, D. Louvard, and E. Coudrier
Rab8 Regulates the Actin-based Movement of Melanosomes
Mol. Biol. Cell, April 1, 2005; 16(4): 1640 - 1650.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. W. Vance, S. Carreira, G. Brosch, and C. R. Goding
Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas
Cancer Res., March 15, 2005; 65(6): 2260 - 2268.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. E. Loercher, E. M.H. Tank, R. B. Delston, and J. W. Harbour
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A
J. Cell Biol., January 3, 2005; 168(1): 35 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. R. Ali, C. Wasmeier, L. Lamoreux, M. Strom, and M. C. Seabra
Multiple regions contribute to membrane targeting of Rab GTPases
J. Cell Sci., December 15, 2004; 117(26): 6401 - 6412.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Gwynn, J. A. Martina, J. S. Bonifacino, E. V. Sviderskaya, M. L. Lamoreux, D. C. Bennett, K. Moriyama, M. Huizing, A. Helip-Wooley, W. A. Gahl, et al.
Reduced pigmentation (rp), a mouse model of Hermansky-Pudlak syndrome, encodes a novel component of the BLOC-1 complex
Blood, November 15, 2004; 104(10): 3181 - 3189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. L. Maldonado, L. Timmerman, J. Fridlyand, and B. C. Bastian
Mechanisms of Cell-Cycle Arrest in Spitz Nevi with Constitutive Activation of the MAP-Kinase Pathway
Am. J. Pathol., May 1, 2004; 164(5): 1783 - 1787.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Wellbrock, L. Ogilvie, D. Hedley, M. Karasarides, J. Martin, D. Niculescu-Duvaz, C. J. Springer, and R. Marais
V599EB-RAF is an Oncogene in Melanocytes
Cancer Res., April 1, 2004; 64(7): 2338 - 2342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. R. Alonso, P. Ortiz, M. Pollan, B. Perez-Gomez, L. Sanchez, M. J. Acuna, R. Pajares, F. J. Martinez-Tello, C. M. Hortelano, M. A. Piris, et al.
Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles: A Tissue Microarray-Based Study
Am. J. Pathol., January 1, 2004; 164(1): 193 - 203.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D'Amico, K. Wu, D. Di Vizio, A. T. Reutens, M. Stahl, M. Fu, C. Albanese, R. G. Russell, W. J. Muller, M. White, et al.
The Role of Ink4a/Arf in ErbB2 Mammary Gland Tumorigenesis
Cancer Res., June 15, 2003; 63(12): 3395 - 3402.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. V. Sviderskaya, V. C. Gray-Schopfer, S. P. Hill, N. P. Smit, T. J. Evans-Whipp, J. Bond, L. Hill, V. Bataille, G. Peters, D. Kipling, et al.
p16/Cyclin-Dependent Kinase Inhibitor 2A Deficiency in Human Melanocyte Senescence, Apoptosis, and Immortalization: Possible Implications for Melanoma Progression
J Natl Cancer Inst, May 21, 2003; 95(10): 723 - 732.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-H. Kim, M. Mitchell, H. Fujii, S. Llanos, and G. Peters
Absence of p16INK4a and truncation of ARF tumor suppressors in chickens
PNAS, January 7, 2003; 100(1): 211 - 216.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. J. Huot, J. Rowe, M. Harland, S. Drayton, S. Brookes, C. Gooptu, P. Purkis, M. Fried, V. Bataille, E. Hara, et al.
Biallelic Mutations in p16INK4a Confer Resistance to Ras- and Ets-Induced Senescence in Human Diploid Fibroblasts
Mol. Cell. Biol., December 1, 2002; 22(23): 8135 - 8143.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.